Lonza and Bar Harbor BioTechnology sign exclusive sales agreement

The strategic alliance between the two companies combines the Cell Discovery busi-ness of Lonza Bioscience and the StellARrayTM products of BHB. Focused gene ex-pression analysis is an important application for primary cells and this agreement en-ables customers to purchase their primary cells and the tools to carry out gene expression from one single source.

“As the leading supplier of primary cells we feel this is a perfect marriage of primary cells, the most relevant cell culture model, to a powerful, easy to use assay platform, that lets researchers really understand what their cells are doing. This agreement with Bar Harbor BioTechnology enables us to better serve our customers with complete cell analysis systems” said Shawn Cavanagh, President of Lonza Bioscience.

“The combination of our products will be a perfect complement to the needs of genetic researchers around the world. Now scientists can attain the biological materials and the tools necessary to perform gene expression experiments from one company” reports Robert Phelps, President of Bar Harbor BioTechnology, Inc. “With Lonza’s global infra-structure and our innovative way of conducting gene expression experiments, we be-lieve the benefit to science will be significant.”

BHB’s StellARray Gene Expression System contains a suite of products comprised of GeneSieve Query, StellARray qPCR arrays, and Global Pattern Recognition (GPR) Analysis Tool. The tools eliminate the need of house keeping gene normalizers and knocks down expression fold change biases that make it difficult to recognize truly significant gene expression changes in a cell. Together they form an integrated group of tools that allow scientists to perform fast, cost effective gene expression research and analyze gene expression data in a new light that could potentially lead to novel discoveries.

Editor's note: Image rights belong to the respective publisher.